Industries de la santé
29 Mai 2012
NEW YORK (GBI Research), 29 May 2012 - Drug resistance and patent expiries are demanding that the antibacterial drug market moves forwards soon, but a current lack of interest from pharmaceutical companies has led to market stagnation, according to a new report by healthcare experts GBI Research. |The new report* shows that while hospital hygiene campaigns to conquer MRSA encourage...